Laboratory diagnosis of the antiphospholipid syndrome
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 108 (5-6) , 263-271
- https://doi.org/10.1016/s0049-3848(02)00400-0
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- The Antiphospholipid SyndromeNew England Journal of Medicine, 2002
- Complexes of anti‐prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfacesBritish Journal of Haematology, 2001
- Beta-2-glycoprotein I Dependent Lupus Anticoagulants Form Stable Bivalent Antibody Beta-2-Glycoprotein I Complexes on Phospholipid SurfacesThrombosis and Haemostasis, 1998
- Anticoagulant Activity of β2-Glycoprotein I Is Potentiated by a Distinct Subgroup of Anticardiolipin AntibodiesThrombosis and Haemostasis, 1992
- Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human ProthrombinThrombosis and Haemostasis, 1991
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- The relationship between lupus anticoagulants and antibodies to phospholipidJAMA, 1988
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.Journal of Clinical Investigation, 1980